AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $281,000 | -12.5% | 18,573 | -14.6% | 0.14% | -42.3% |
| Q2 2020 | $321,000 | +34.9% | 21,759 | +23.3% | 0.25% | -14.9% |
| Q1 2020 | $238,000 | -69.6% | 17,642 | -45.5% | 0.29% | -49.4% |
| Q4 2019 | $782,000 | +180.3% | 32,357 | +450.9% | 0.57% | +160.7% |
| Q1 2019 | $279,000 | -86.1% | 5,873 | -80.2% | 0.22% | -88.4% |
| Q2 2018 | $2,001,000 | +44.8% | 29,629 | +16.3% | 1.88% | +80.1% |
| Q1 2018 | $1,382,000 | +228.3% | 25,472 | +261.2% | 1.04% | +309.8% |
| Q4 2017 | $421,000 | – | 7,053 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |